not tagged
not tagged
[]
#ectrims2022 hot topic 1: hugh efficacy therapies in ms. , dalia rotstein and review which baseline poor prognosis factors are also relevant for treatment response, the importance of timely switch and giving patients the choice of starting het. 
Neurologist, specialist in multiple sclerosis and related disorders